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Introduction
In bacteria, disulfide-bond formation occurs in the periplasm and is mediated by the disulfide-bond (Dsb) family of proteins (Heras et al., 2007 (Heras et al., , 2009 Kadokura & Beckwith, 2010) . In most Gammaproteobacteria, Dsb proteins form a two-pathway system. In the oxidation pathway, DsbA and its cognate oxidase DsbB introduce disulfide bonds into newly translocated proteins that are undergoing oxidative folding in the periplasm (Kamitani et al., 1992; Bardwell et al., 1993; Missiakas et al., 1993; Depuydt et al., 2011) . The isomerase pathway is composed of the isomerase DsbC and the reductase DsbD, which are responsible for reshuffling non-native disulfide bonds formed by the DsbA/DsbB system (Cho & Collet, 2013; Missiakas et al., 1994 Missiakas et al., , 1995 Rietsch et al., 1996) . DsbD is a 59 kDa integral membrane reductase that transfers electrons from the cytoplasm to periplasmic substrate proteins (Arts et al., 2015; Cho & Collet, 2013; Rietsch et al., 1997) . Escherichia coli DsbD (EcDsbD) consists of a membrane-spanning domain, t-DsbD, flanked by two periplasmic domains, n-DsbD and c-DsbD (Katzen et al., 2002; Cho et al., 2007) . The N-and C-terminal domains of DsbD # 2018 International Union of Crystallography adopt an immunoglobulin-like and a thioredoxin-like fold, respectively (Rozhkova et al., 2004) . t-DsbD is membraneembedded and consists of eight -helices (Cho & Beckwith, 2009) . Each DsbD module harbours two catalytic cysteines, which allow efficient electron flow through the three DsbD domains via a sequential cascade of thiol-disulfide exchange reactions (Stewart et al., 1999; Katzen & Beckwith, 2000) . This process begins with oxidized t-DsbD, which accepts electrons from reduced cytoplasmic thioredoxin, leaving t-DsbD reduced and thioredoxin oxidized (Stewart et al., 1999) . Reduced t-DsbD undergoes a conformational change which allows interaction with and reduction of c-DsbD (Cho & Collet, 2013) . The latter domain reduces n-DsbD, which then reduces disulfides in its periplasmic substrates (Arts et al., 2015) such as DsbC, CcmG and DsbG (Stirnimann et al., 2005; Depuydt et al., 2009) .
Dsb proteins promote multiple virulence phenotypes and regulate the redox balance in the cell envelope, but in general these proteins are not required for survival. However, this is not the case in Neisseria meningitidis, where DsbD (NmDsbD) was found to be essential for the viability of this obligate human pathogen (Kumar et al., 2011) . We are interested in investigating the structural and functional characteristics of NmDsbD in order to understand the molecular basis of this uncommon phenotype. Furthermore, this information could form the basis for the future development of antineisserial agents targeting DsbD (Smith et al., 2016) . Here, we report the expression, biophysical characterization, crystallization and preliminary X-ray diffraction data for the two periplasmic domains of NmDsbD in both redox states.
Materials and methods

Macromolecular production
For the expression of the N-and C-terminal domains of NmDsbD (residues 1-124 and 465-579, respectively, of the mature protein), the corresponding coding regions were PCRamplified from N. meningitidis strain NMB genomic DNA. Ligation-independent cloning (LIC) was then used to insert the sequences into bacterial expression vector pMCSG7 (Eschenfeldt et al., 2009 ). The final constructs contained an N-terminal His 6 tag that preceded a Tobacco etch virus (TEV) protease cleavage site. This tag is used in the purification of the proteins and is cleaved during the process, leaving two additional residues (SN) on n-NmDsbD and three additional residues (SNA) on c-NmDsbD (Table 1) .
Plasmid constructs pMCSG7::n-NmdsbD and pMCSG7:: c-NmdsbD were transformed into E. coli BL21 (DE3) pLysS cells. n-NmDsbD and c-NmDsbD were expressed using the autoinduction method (Studier, 2005) . Briefly, E. coli BL21 (DE3) pLysS cells harbouring n-NmDsbD-and c-NmDsbDcontaining plasmids were grown at 303 K for 24 h with agitation at 180 rev min À1 in rich (ZY) medium supplemented with 100 mg ml À1 ampicillin and 34 mg ml À1 chloramphenicol (typically to a final optical density at 600 nm in the range between 4 and 5). Bacterial cultures were harvested by centrifugation (7500g, 20 min, 277 K) and flash-frozen before storage at 183 K.
For purification, harvested pellets were resuspended in 25 mM Tris pH 8.0, 150 mM NaCl supplemented with EDTAfree protease-inhibitor cocktail tablets and 400 units of DNase I per litre of culture. Cells were lysed using a bench-top cell disruptor (one cycle at 241 MPa; TS series, Constant Systems Ltd). Cellular debris was removed from the lysate via centrifugation (30 000g, 20 min, 277 K) and the lysate was loaded onto a 5 ml HisTrap FF column (GE Healthcare). Proteins were eluted from the column in 25 mM Tris pH 8.0, 150 mM NaCl and a gradient of 0-500 mM imidazole using a Bio-Rad NGC system. Recombinant His-tagged TEV protease (Cabrita et al., 2007) was added to fractions containing His 6 -n-NmDsbD and His 6 -c-NmDsbD (0.2 and 0.4 mg TEV protease per 10 mg of protein, respectively) supplemented with 5 mM reduced dithiothreitol (DTT Red ) and samples were dialyzed overnight against 25 mM Tris pH 8.0, 150 mM NaCl. The samples were further purified using a 5 ml HisTrap FF column followed by size-exclusion chromatography (SEC) using a Superdex S-75 16/60 column (GE Healthcare) preequilibrated in 25 mM HEPES pH 6.7, 150 mM NaCl. The target proteins were oxidized using 1.7 mM copper phenanthrolene or reduced using 40 molar equivalents of reduced DTT and incubated for 1 h at 277 K. Oxidized and reduced proteins were buffer-exchanged into 25 mM HEPES pH 6.7, 50 mM NaCl and the same buffer supplemented with 1 mM EDTA using a 10 ml PD10 column (GE Healthcare) prior to crystallization experiments. The redox state of the NmDsbD domains was confirmed by Ellman's assay (Evans & Ellman, 1959) . 
Small-angle X-ray scattering (SAXS) studies
SAXS data for n-NmDsbD and c-NmDsbD were collected on the SAXS-WAXS beamline at the Australian Synchrotron (Kirby et al., 2013;  Table 2 ). Serial dilutions of an $5 mg ml À1 stock were loaded into a 96-well plate. The estimated molecular mass was calculated using contrast and partial specific volumes determined from the protein sequences (Whitten et al., 2008) . The pair-distance distribution function [p(r)] was generated from the experimental data using GNOM (Svergun, 1992) , from which I(0), R g and D max were determined (Figs. 1a  and 1b) . The program DAMMIN (Svergun, 1999) was used to generate 16 molecular envelopes for each protein, which were averaged using the program DAMAVER (Volkov & Svergun, 2003) , and the resolutions of the averaged structures were estimated using SASRES (Tuukkanen et al., 2016) . The experimental scattering data were compared with scattering curves calculated from the crystal structures of the corresponding domains from E. coli [n-EcDsbD, PDB entry 1l6p (Goulding et al., 2002) , and c-EcDsbD, PDB entry 1uc7 (Kim et al., 2003) ] using CRYSOL (Svergun et al., 1995) (Fig. 1 ).
Crystallization
Initial high-throughput crystallization experiments were performed at 293 K either in-house using a Mosquito crystallization robot (TTP Labtech) or a Crystal Gryphon Liquid Handling System (Art Robbins Instruments) or at the CSIRO Collaborative Crystallisation Centre (http://www.csiro.au/C3), Melbourne, Australia. For n-NmDsbD Ox , c-NmDsbD Ox , n-NmDsbD Red and c-NmDsbD Red , 96-well hanging-drop plates were prepared using 71, 44, 60 and 20-40 mg ml À1 protein solutions, respectively, and commercially available crystallization screens (Crystal Screen, Crystal Screen 2, PEG/Ion, PEG/Ion 2, Index and Salt RX from Hampton Research, PACT premier and JCSG-plus from Molecular Dimensions Ltd and Precipitant Synergy from Jena Bioscience) and an inhouse malonate grid screen (pH 5-7 and 0.2-3.4 M malonate).
Initial crystallization experiments for the reduced proteins (n-NmDsbD Red and c-NmDsbD Red ) were performed using a Crystal Gryphon Liquid Handling System (Art Robbins Instruments). Crystallization experiments for n-NmDsbD Red were set up with 60 mg ml À1 protein solution, whereas experiments for c-NmDsbD Red were set up with both 20 and 40 mg ml À1 protein solutions. 96-well sitting-drop plates (200 nl protein solution and 200 nl reservoir solution equilibrated against 70 ml reservoir solution) were prepared using commercially available crystallization screens (PEG/Ion 1 and 2, Salt RX, Index, Crystal Screen and Crystal Screen 2 from Hampton Research and PACT premier, JCSG-plus and Morpheus from Molecular Dimensions Ltd).
All crystal-optimization experiments were carried out at 293 K in 24-well hanging-drop VDXm plates using 18 mm siliconized cover slips (Hampton Research), a reservoir volume of 500 ml and a drop size of 2 ml (1 ml protein and 1 ml reservoir solution).
Crystals of n-NmDsbD Ox only grew in 20%(w/v) PEG 6000, 0.01 M zinc chloride, 0.1 M MES pH 6 (PACT premier). This condition was optimized by varying different components and diffraction-quality single hexagonal crystals (Figs. 2a and 2c ) grew overnight using protein at 66 mg ml À1 in 18-20%(w/v) PEG 6000, 0.1 M MES pH 6.4, 0.02 M ZnCl 2 .
Initial screening for n-NmDsbD Red produced microcrystals in 2.5 M ammonium sulfate, 0.1 M Tris pH 8.5 (condition 1; from Salt RX), 0.1 M HEPES pH 7.5, 1.4 M sodium citrate tribasic dehydrate (condition 2; from Index), 5% Tacsimate pH 7.0, 0.1 M HEPES pH 7.0, 10%(w/v) PEG MME 5000 (condition 3; from Index), 0.1 M ammonium citrate tribasic pH 7.0, 12%(w/v) PEG 3350 (condition 4; from Index), 20%(w/v) PEG 3350, 0.2 M potassium nitrate (condition 5; from JCSG) and 0.1 M bis-tris propane pH 7.5, 20%(w/v) PEG 3350, 0.2 M sodium nitrate (condition 6; from PACT premier).
Optimization screens were prepared using protein at 30 and 60 mg ml
À1
, and the best initial hits and small hexagonal diffraction-quality crystals (Figs. 2b and 2d ) grew amongst salt crystals within 2 d in 2.5 M ammonium sulfate, 0.1 M Tris pH 9.1 with a protein concentration of 60 mg ml
. Initial screening of c-NmDsbD Ox yielded crystals in only one condition consisting of 5%(w/v) PEG 400, 2 M sodium citrate/citric acid pH 7.5 (Precipitant Synergy), and diffractionquality crystals were obtained using protein at 42-38 mg ml À1 in 5%(w/v) PEG 400, 1.7-2.2 M citrate/citric acid pH 7.0-7.8. , decreasing from $17.5 Å at 0.37 mg ml À1 to $16 Å at 5.88 mg ml À1 . The 0.74 mg ml À1 data set was used for further analysis and modelling as it was deemed to be the highest concentration at which the effects of concentration were negligible. The change in R g for c-NmDsbD showed no obvious systematic trend in the concentration range measured. A concentration of 1.12 mg ml À1 was chosen for further analysis and modelling.
These thin spear-shaped crystals grew under a skin after between 4 and 8 d (Figs. 3a and 3c) .
Initial screening of c-NmDsbD Red yielded crystals in the following conditions: 0.2 M zinc acetate dehydrate, 0.1 M sodium cacodylate trihydrate pH 6.5, 18%(w/v) PEG 8000 (condition 1), 2.4 M sodium malonate pH 7 (condition 2), 0.1 M Tris-HCl pH 8.5, 2 M ammonium sulfate (condition 3; from Crystal Screen), 2 M ammonium sulfate (condition 4; from Crystal Screen) and 2.1 M dl-malic acid (condition 5; from JCSG-plus). Diffraction-quality crystals of c-NmDsbD Red were obtained using protein at 30 mg ml À1 in 0.2 M zinc acetate dihydrate, 0.1 M sodium cacodylate trihydrate pH 7.5, 18%(w/v) PEG 8000. Clustered crystals grew in 3 d, or overnight with microseeding, and were subsequently manipulated to isolate single crystals for diffraction data collection (Figs. 3b  and 3d ).
All final crystallization conditions for the crystals used for data collection are described in Table 3 . Small-angle X-ray scattering from n-NmDsbD and c-NmDsbD. (a) Measured scattering data for n-NmDsbD (red) and c-NmDsbD (blue; scaled by a factor of 0.1 for clarity). Overlaid are the calculated scattering curves for n-EcDsbD (PDB entry 1l6p; black curve, 2 = 2.38) and c-EcDsbD (PDB entry 1uc7; yellow curve, 2 = 1.65). Inset: Guinier plots of the scattering data. (b) The pair-distance distribution functions for n-NmDsbD (red) and c-NmDsbD (blue). (c) Probable domain shapes for n-NmDsbD (SASBDB entry SASDCH7; red envelope, resolution = 19 AE 2 Å ) and c-NmDsbD (SASBDB entry SASDCJ7; blue envelope, resolution = 18 AE 2 Å ) obtained from ab intio modelling against the scattering data. The crystal structures of n-EcDsbD (PDB entry 1l6p) and c-EcDsbD (PDB entry 1uc7) are shown as cartoons. The grey envelopes represent the total volume encompassed by the 16 aligned models for n-NmDsbD ( 2 = 1.90 AE 0.01) and c-NmDsbD ( 2 = 1.60 AE 0.01).
X-ray diffraction data measurements
For diffraction data measurements, n-NmDsbD Ox , c-NmDsbD Ox and n-NmDsbD Red crystals were cryoprotected by soaking them for 2 min in mother liquor supplemented with 20% glycerol, PEG 400 and glycerol, respectively. c-NmDsbD Red crystals were cryocooled in reservoir solution. X-ray diffraction data were collected at 100 K on the microfocus beamline (MX2) at the Australian Synchrotron using an ADSC Quantum 315r detector. Diffraction data were collected over a total angular rotation of 180 for both the n-NmDsbD Ox and n-NmDsbD Red crystals, with an oscillation angle of 1 and an exposure time of 1 s. A total of 180 of diffraction images were also collected for the c-NmDsbD Ox crystal, with an oscillation angle of 0.5
and an exposure time of 1 s. For the c-NmDsbD Red crystal the oscillation range per image was 1 over a total angular rotation of 200 , with an exposure time of 0.5 s. Diffraction data were indexed, integrated and scaled using HKL-2000 (Otwinowski & Minor, 1997) for the n-NmDsbD Ox and c-NmDsbD Ox data sets, and using iMosflm (Battye et al., 2011) and AIMLESS from the CCP4 suite (Winn et al., 2011) for the n-NmDsbD Red and c-NmDsbD Red data sets.
Results and discussion
The two periplasmic domains of the thiol-disulfide reductase DsbD from N. meningitidis, n-NmDsbD and c-NmDsbD, were recombinantly expressed in E. coli and purified to homogeneity using three chromatographic steps (affinity, reverse affinity and size-exclusion chromatography) for crystallization trials.
We first analyzed n-NmDsbD and c-NmDsbD using SAXS not only to determine the quality of the recombinant proteins in solution but also to obtain low-resolution information on the shape and conformation of these domains (Fig. 1) . The SAXS data displayed a low experimental noise level, with a linear Guinier plot consistent with a homogeneous, monodisperse solution of both NmDsbD domains. The molecular weights of n-NmDsbD and c-NmDsbD estimated from extrapolation to I(0) were 13.2 and 11.9 kDa, respectively. Ab initio modelling was employed to determine the lowresolution structure of both domains. Figure 3 models were generated and subsequently aligned, averaged and filtered to produce the probable shape of the protein (Fig. 1c) . The agreement between the crystal structures of the n-EcDsbD and c-EcDsbD domains and the red and blue envelopes provides convincing evidence that the n-NmDsbD and c-NmDsbD domains adopt similar three-dimensional structures in solution to their E. coli counterparts. Despite the only difference between n-NmDsbD Ox and n-NmDsbD Red or c-NmDsbD Ox and c-NmDsbD Red being the presence or absence of a disulfide bond, the domains crystallized in different conditions in their two redox forms. Single crystals of n-NmDsbD Ox grew in 18-20%(w/v) PEG 6000, 100 mM MES pH 6.4, 20 mM ZnCl 2 . n-NmDsbD Red crystals were obtained in 2.5 M ammonium sulfate, 0.1 M Tris pH 9.1. c-NmDsbD Ox crystallized in 5%(w/v) PEG 400, 1.7-2.2 M citrate/citric acid pH 7.0-7.8 and crystals of c-NmDsbD Red grew in 0.2 M zinc acetate dehydrate, 0.1 M sodium cacodylate trihydrate pH 7.5, 18%(w/v) PEG 8000 (Figs. 2 and 3) . The n-NmDsbD Ox , n-NmDsbD red , c-NmDsbD Ox and c-NmDsbD Red crystals diffracted to resolutions of 2.3, 1.6, 2.3 and 1.7 Å and belonged to space groups P2 1 3, P321, P4 1 and P12 1 1, respectively. Assuming that the n-NmDsbD Ox , n-NmDsbD Red , c-NmDsbD Ox and c-NmDsbD Red crystals contain six, two, two and one molecules per asymmetric unit, respectively, their respective Matthews coefficients (V M ) are 3.19, 3.29, 2.29 and 2.09 Å 3 Da À1 and their corresponding solvent contents are 61. 50, 62.65, 46.37 and 41.17%, respectively (Matthews, 1968) . Diffraction data statistics are shown in Table 4 . Further studies are in progress to elucidate the structure and mode of action of these catalytic domains in NmDsbD. 
